Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases

Małgorzata Rogaczewska; Marcin Stopa

doi:10.5114/ko.2021.104752

POLSKI

eISSN: 2719-3209
ISSN: 0023-2157

Klinika Oczna / Acta Ophthalmologica Polonica

Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2021
vol. 123

Send email

Copy url:

abstract:

Case report

Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases

Małgorzata Rogaczewska

¹

,

Marcin Stopa

¹

Department of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, Poznan, Poland

KLINIKA OCZNA 2021, 123, 1: 42–45

DOI: https://doi.org/10.5114/ko.2021.104752

Online publish date: 2021/03/31

View full text Get citation

PlumX metrics:

We present a report of two patients with active ocular toxoplasmosis treated with intravitreal clindamycin. The location of the retinochoroiditis close to the optic disc validated the injection of 1 mg clindamycin, even though the visual acuity was not diminished. After 7 days, inflammatory lesions and vitritis regressed significantly. Moreover, no side effects occurred.

keywords:

Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases

Małgorzata Rogaczewska 1 , Marcin Stopa 1

Toxoplasma gondii, clindamycin, intravitreal injection, toxoplasmic retinochoroiditis

Małgorzata Rogaczewska

¹

,

Marcin Stopa

¹